Biotech / Medtech Archives | citybizSciencenews

Sangamo Therapeutics Files for Chapter 11 Bankruptcy Protection

Tuesday, June 23, 2026Win WarfieldView original

Sangamo Therapeutics Inc. (NASDAQ: SGMO), a clinical-stage biotechnology company focused on genomic medicine, has filed for Chapter 11 bankruptcy protection... Read More

The post Sangamo Therapeutics Files for Chapter 11 Bankruptcy Protection appeared first on citybiz.